A randomized, double-blind, multicenter, parallel study evaluating the efficacy and safety of a combination of ramipril plus hydrochlorothiazide versus the component monotherapies in subjects with essential hypertension.

Trial Profile

A randomized, double-blind, multicenter, parallel study evaluating the efficacy and safety of a combination of ramipril plus hydrochlorothiazide versus the component monotherapies in subjects with essential hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2012

At a glance

  • Drugs Hydrochlorothiazide; Ramipril
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors King Pharmaceuticals Research and Development
  • Most Recent Events

    • 01 Aug 2008 Primary endpoint 'Diastolic blood pressure' has been met. Results published in Journal of Human Hypertension
    • 12 Nov 2007 Status changed from in progress to completed
    • 26 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top